Arena Pharmaceuticals, Inc. (ARNA)

[motohead125]

x2. The valv results in this study were consistent with those in the other 2 LARGE population studies designed to rule out Valvulopathy. This study proves nothing different. The placebo went from 1.9% to .5%, sooo fat people hearts on the placebo pill got better? Not likely. They probably dropped out shortly into the trial because they weren't losing weight. Still preliminary results that need to be looked at. We'll see what the fda says later this year after they review the DM results.